Helping Manage Symptoms

Living with Crohn’s disease or ulcerative colitis often means dealing with pain, weight loss, fatigue, anemia or diarrhea.

With the support of grants from Crohn's and Colitis Canada, the researchers noted below are conducting research projects that focus on developing a better understanding of these symptoms with the goal of discovering novel treatments that will reduce or even eliminate symptoms altogether.

2022 Grant Recipients

Dr. Eileen Crowley
Dr. Eileen Crowley | London Health Sciences Centre
Research: Understanding inflammatory arthritis among people living with IBD
Date: 2022-2025
Amount: $375,000
IBD is a systemic disease which can affect multiple organ systems. Up to 30% of people living with IBD may have inflammatory arthritis. However, there is little data published on the prevalence, use of health services, and complications for this sub-group to date.
Dr. Crowley and her team will be conducting the first Canadian population-based study to understand the prevalence of inflammatory arthritis in IBD patients, and the use of opioids and healthcare services among this sub-group. The outcomes of this study will help improve the quality of life and patient services for people affected by inflammatory arthritis and IBD.
Dr. Dana Philpott
Dr. Dana Philpott | University of Toronto
Research: Unravelling the link between Crohn’s Disease and Type-2 Diabetes
Date: 2022-2023
Amount: $50,000
Crohn’s disease is an inflammatory condition that causes complications in other parts of the body outside the gut. Recent research has shown that Crohn’s disease patients have an increased risk of developing type-2 diabetes. However, the mechanism that causes Crohn’s disease patients to develop type-2 diabetes is not well understood. Preliminary studies have shown that a compromised gut lining and an imbalance of microbes may be a contributing factor for both conditions.
Dr. Philpott plans to further investigate the interplay between the causes of Crohn’s disease and type-2 diabetes in order to improve care in the future for IBD patients with complications.


To learn about the 2019-2021 research projects we supported, click here.
To learn about the 2018 research projects we supported, click here.
To learn about the 2014 -2017 research projects that we have supported, click here.

  • Canada has among the highest incidence rates of Crohn's and colitis in the world.
  • 1 in 140 Canadians lives with Crohn’s or colitis.
  • Families new to Canada are developing these diseases for the first time.
  • Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
  • People are most commonly diagnosed before age 30.

Other Areas of Interest